Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG for Parathyroid Perfusion in Thyroidectomy
NCT03969108Phase 4Completed
- Sponsor
- University Health Network
- Start
- Aug 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in thyroid cancer, Graves' disease and goiter, sponsored by University Health Network. Primary endpoint: Quantification of the fluorescent signal of ICG. Started Aug 2019; status: completed.
02
Drugs
indocyanine green
03
Conditions
thyroid cancerGraves' diseasegoiter
Beyond the preview
Go deeper on NCT03969108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969108.